are consistent with the hypothesis that the strychnine-insensitive glycine binding site is closely associated with the N-methyl-D-aspartate receptor<hannel complex. These data also suggest that the stoichiometry between these binding sites is approximately
I : 3 : 4 (thienylcyclohexylpiperidine :
glycine:glutamate) in stratum radiatum of area CAI. However, in other brain regions, there were more glycine than glutamate binding sites suggesting that there may be heterogeneity in the N-methyl-Daspartate receptor<hannel complex
The N-methyl-D-aspartate (NMDA)-subtype of glutamate receptors is part of a receptor-ion channel complex with multiple regulatory sites including $To whom correspondence should be addressed. Abbrmiutions: AP5, DL-2-amino-5-phosphonopentanoic acid; AP7, DL-2-amino-7-phosphonoheptanoic acid; APB, DL-2-amino-4-phosphonobutyric acid; ASP-AMP, beta-Daspartyl-aminomethylphosphonic acid; DGG, gamma-D-glutamylglycine;
GAMS, gamma-D-glutamylaminomethylsulfonate; GDEE, L-glutamyl-diethylester; HA-966, 3-amino-I-hydroxypyrollid-2-one; HPLC, high pressure liquid chromatography;
LGG, gamma-L-glutamylglycin& L-SOS, L-ser&e:O&lfate;
?$K-801, {(y )- 
EXPERIMENTAL PROCEDURES

Mtrtwial.\ ['H]Glycine
was obtained from Amersham (Arlington Heights, IL. U.S.A., specific activity = 13. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] .
[IL-2-Amino-4-phosphonobutyric acid (APB). uL-2-amino-5.phosphonopentanoic acid (AP5), uL-2-amino-7-phosphondheptanoic &d (AP7), gamma-o-glutamylamino-methylsulfonate (GAMS), gamma-u-glutamylglycine (DGG). gamma-L-giutamylglyci~e (LGG), L-gl;ta&yl-diethylester (GDEE), beta-D-aspartyl-aminomethylphosphonic acid (ASPS-AMP), u-homocysteine sulfinic acid, 7-chlorokynurenate, and 3-amino-1-hydroxypyrollid-2-one (HA-966) were obtained from Tocris Tissue sections were preincubated in 50 mM Tris citrate (pH 7.4) at 4 C for 30 min to remove endogenous compounds and then dried under a stream of cool air. In preliminary experiments this length of preincubation was determined to maximize ['Hlglycine binding while maintainmg tissue integrity. Longer preincubation periods of up to 2 h at 4 C did not further enhance binding. In regional distribution studies. sections were then incubated in the same buffer (pH 7.4) containing 1OOnM ['Hlglycine for 35 min at 4 C (final volume = 8 ml); under these conditions, less than 5% of free ligand was bound and "zone A" conditions were maintained. In preliminary experiments. ['Hlglycine binding in rat forebrain was found to be insensitive to the addition of 100pM strychnine.
In saturation studies. the concentration of ['Hlglycine was 40 nM and varying amounts of unlabeled glycine were included in the incubation buffer to give final concentrations of glycine ranging from 41 nM to 2.5 PM. Non-specific binding was determined in the presence of I mM unlabeled glycine and represented less than 10% of total binding at a concentration of 100 nM [?H]glycine."
Following the incubation, sections were rinsed three time, with 2 ml ice-cold buffer followed by a final rinse with 2 ml Ice-cold glutaraldehyde (49%): acetone mixture (1: 19 v/v) and quickly dried under a warm stream of air to minimize uneven ligand dissociation.
Preliminary experiments determined that this rinse procedure optimized the ratio of specific to non-specific binding. Maximum rinse time wa\ less than 5 s.
Tissue sections were apposed to tritium-sensitive tilm (LKB Ultrofilm 'H) for two to six weeks. A set of radioactive standards (American Radiochemicals, ARC c'l4) calibrated against whole brain pastes with known amounts of protein--tritium was exposed with each film. Protein values of whole brain paste sections were determined by the Lowry method. Quantitative analysis of the resulting autoradiograms was performed densitometrically using a microcomputer Binding to the strychnine-insensitive glycine site in hippocampal area CA1 was reduced by raising the temperature from 4 to 37°C. Relative to 4°C binding at 23°C was reduced by 52 f 6%. Incubation at 37°C reduced binding by 68 + 8%.
Strychnine-insensitive glycine binding was very sensitive to changes in pH (Fig. 1) . Specific binding of [3H] glycine was studied at 10 pH values ranging from 4.0 to 10.0. Binding in the stratum radiatum of CA1 was optimal in the narrow pH range 7.0-7.5. At a concentration of 100 nM [3H]glycine, binding in the stratum radiatum of the CA1 area in rat brain reached equilibrium rapidly at 4°C and remained at equilibrium for at least 2 h (Fig. 2) (Fig. 3) .1. W. MCDO\AI 1) 1'1 (11 . probably reflects the ditfculty in accurately determining the association rate constant due to fast dissociation of glycine. Similar K, values were obtained in other brain regions (Table I ).
The level of glycine contamination in commercial compounds as assessed by either thin layer chromatography or high pressure liquid chromatography varied considerably between compounds. Less than 0. I % glycine contamination was present in the majority of compounds tested. However, I)L-AP5 (from two sources) contained approximately 1% glycine. NMDA and glutamate were also contaminated with low levels of glycine (O.Ol-0.1%). Distinct binding sites on the NMDA rcccptor~ channel complex have been described for the cations. magnesium and zinc. The diff'erential effects of these two ions on specific strychnine-insensitive glycine binding is illustrated in Fig. 4 . Magnesium enhanced ['Hlglycine binding over the concentration range, 0. I IO mM (P < 0.05, ANOVA). Binding was maximally increased to I20 + 7% of control at IO mM magnesium.
Binding was slightly reduced at IO ii M magnesium. In contrast. zinc inhibited glycine binding over the concentration range of 10 PM--IO mM (P < 0.005, ANOVA). Ten millimolar zinc maximally reduced binding to 68 k 3% of the control value. The potencies of glycine and both the u-and L-isomers of serine, alanine and valine are presented in Table 2 . Of these amino acids, giycine was the most potent inhibitor of strychnine-insensitive glycine binding with a K, value of 0.13 k 0.02 I'M. In general the D-amino acid isomers were more potent than the corresponding L-forms. The rank order of potency in displacing glycine binding was: glycine > D-serine > n-aianinc > L-serine > I.-alanine > I.-valine > o-vaiine. All these amino acids produced complete inhibition of glycine binding with the exceptions of u-and L-valine which were only evaluated up to concentrations of IOmM. All Hill coefficients were near unity. (Fig. 5) . In stratum radiatum of CA I. 7-chlorokynurenate was 41 times more potent than in inhibiting ['Hfglycine binding; K, values were 0.27 + 0.03 !tM (7-chlorokynure~te) and I I. 1 1 i 0.89 ,U M (HA-966). Hill coefficients were near unity indicating that these ligands are acting at ;L single population of glycine sites under the present conditions. 
l?flkct of amino acid-containing compounds
With the exception of the simple amino acids described above, none of the other amino acids tested altered glycine binding. Of note, taurine, which has been demonstrated to inhibit high affinity glycine uptake in the rat forebrain, does not displace strychnine-insensitive ['Hlglycine binding. The methyl ester derivative of glycine completely inhibited glycine binding.
In addition to the amino acid-containing compounds above, several dipeptides also significantly reduced binding. Glutamyland aspartyl-glycine both reduced binding by greater than 80% while N-glycylglycine only reduced binding by 62% (P < 0.001. ANOVA).
Efltict of GABA receptor ligands
None of the GABA derivatives tested significantly altered strychnine-insensitive glycine binding at concentrations of 100 PM.
Regional distribution qf' strychnine -insensitice glycine binding sites
Strychnine-insensitive glycine binding to rat brain sections exhibited a marked regional heterogeneity, with the highest binding density present in the stratum radiatum of the CA1 hippocampal subfield (Table 4 and Fig. 6 ). Essentially all brain regions showed strychnine-insensitive glycine binding. Within laminated structures, dendritic zones generally had the greatest density of binding with less binding in cellular layers. In general, binding decreased at caudal levels of the neuroaxis.
Within the telencephalon, the rank order of binding density was hippocampal formation > cerebral cortex > olfactory nuclei > basal ganglia > diencephalic nuclei. Midbrain structures exhibited the least amount of binding and the cerebellum was intermediate.
Within the olfactory bulb, a distinct laminar distribution of glycine binding was present (Fig. 6b) ; the greatest density of binding was in the external plexiform layer (43% of maximum), intermediate levels in the internal granule layer, and lowest density in the glomerular layer. In addition to the high binding density in the olfactory bulb, the medial and lateral olfactory nuclei also exhibited a high degree of binding (75% of the maximum density of glycine sites).
Cerebral cortical regions demonstrated moderate to high levels of binding. The density of binding varied widely within cortical layers with greatest variation between different cortical regions (up to two-fold). Generally, binding density decreased from superficial to deep cortical layers with the homogeneous distribution pattern present in the entorhinal cortex being the exception. Of the cortical regions, the cingulate had the highest binding density and the frontal and frontoparietal regions exhibited lower levels of glycine binding.
The basal ganglia also revealed a heterogeneous pattern of binding. Binding was greatest in the caudateeputamen, moderate in nucleus accumbens, and low in globus pallidus. Very little binding was present in the entopeduncular nucleus. Marked variation in binding was also observed within these structures. In the corpus striatum. 69% of maximal CAI binding was present in the ventral posterior region, 55% ventroanteriorally, 44% dorsomedially, and 38% dorsolaterally.
In addition, binding densities in the posterior globus pallidus were nearly three times that present more anteriorally.
The lateral septum exhibited 43% of maximal CA1 binding while less binding was present in the other basal forebrain structures.
In general, the diencephalic nuclei had moderate levels of ['Hlglycine binding. Various nuclei were readily distinguished by the amount of glycine bound. The medial dorsal nucleus had the greatest density of binding, and the habenula contained the fewest binding sites. The anterior ventral, ventral lateral and ventral posterior medial nuclei possessed equivalent levels of binding (46% maximum). The medial and lateral geniculate were readily distinguishable with slightly higher binding in the former. Binding in the nucleus reunions was only 35% of maximum.
The hippocampal formation exhibited a very distinctive laminar distribution of glycine binding (Fig. 6a) that was similar to the topography of NMDA-sensitive glutamate binding (Fig. 7) .'xJ'JZ The maximal density of binding sites observed anywhere in the brain was found in the stratum radiatum of area CAI. Within the hippocampus, levels were Brainstem structures exhibited low levels of binding with the exception of moderate levels present in the central gray, the inferior colliculus and in the substantia nigra. In the cerebellum, distinct laminar binding was observed. Density levels were low in the molecular layer which is the Purkinje cell dendritic zone. Binding in the granule cell layer of the cerebellum was 30% of maximal binding density (seven times greater than the molecular layer). It is unlikely that [3H]glycine binding represents an enzymatic or transport binding site*' or simple sequestration since strychnine-insensitive glycine binding was maximal at 4°C and was greatly reduced at 23 or 37-C. In addition, the KD determined by kinetic experiments was similar to equilibrium K, suggesting that sequestration is unlikely to play a role in binding. Binding was highest in areas where glycine uptake is lowest. Furthermore, inhibitors of high affinity glycine uptake described in rat forebrain, such as taurine, are ineffective displacers of binding. Taken together with the evidence described above, the high degree of concordance between the distribution of strychnine-insensitive glycine binding sites and the distributions of [3H]TCP and NMDAsensitive glutamate binding sites strongly suggest that the site labelled by [3H]glycine in this study represents the physiologically defined receptor. Zinc also selectively antagonizes the NMDA reccptor channel in electrophysiological.
Comparison of the distribution of binding sites comprising the N-methyl-D-uspnrtate receptor-c~hunnrl complex
biochemical, and ncurotoxicity studies but at a site which is distinct from the magnesium binding site.'i.""" ". cerebral cortex. olfactory bulb. caudateeputamen and lateral septum, with littlc staining present in the brainstcm and cerebellum. Since high micromolar concentrations of zinc may be achieved in the synaptic cleft upon stimulation. zinc may act as a negative modulator of the NMDA receptor-channel if7 could account for the level of ['Hlglycine displacement produced by 100 p M AP5. AP4 and AP7 contained less than 0. I % glycine and this level of glycine contamination would be expected to inhibit ['Hlglycine binding by less than 30% at 1OOpM AP4 or AP7 (accounting for the degree of inhibition of binding produced by these two compounds). In contrast, the level of glycine present in the glycine containing dipeptides (Iess than 0.1%) cannot explain the inhibition of PHjglycine produced by these dipeptides since they all produced 60-100% inhibition of binding at 100 PM concentrations. Most other effective displacers of 13H]glycine binding as well as inactive compounds (NMDA, glutamate) contained low levels of glycine contamination which could not account for their effects on [jH]giycine binding.
The problem of glycine contamination of commercial compounds, water supplies, and glassware may complicate the interpretation of studies examining the function of excitatory amino acid receptor modulators. In autoradiographic experiments, endogenous glycine in the tissue sections is always an issue despite extensive washes. In some patch clamp or binding studies using extensively washed membranes where glycine contamination is thought to be minimal, the levels of glycine in commercial materials becomes problematic. The purity of compounds used in studies of this modulator site should be considered in the interpretation of the results.
Structural requirements of ~tr~~h~~ne-insensitive givcitw receptor ligands
The structure-activity relations of glycine receptor ligands that can be determined from the inhibition studies of ['H]glycine binding in Tables 1 and 2 confirm and extend results from previous studies of structureeactivity relations.s6 The D-forms of simple alpha-amino acids are in general more potent displacers than the L-forms (about 80 times) of strychnine-insensitive glycine binding. This stereospecificity is similar to the structural requirements of antagonists of the NMDA recognition site.46 A hydrogen on the alpha carbon (glycine), a methylenehydroxyl group (serine), or a methylene-O-sulfate group L-serine-O-sulfate (L-SOS) is more active than a single methyl group while all compounds with aspartate length side chains are not active. Of compounds with glutamate-length side chains, the order of activity with respect to the terminal acid group is SO,H > PO, H, > COOH.
The number of atoms separating the amino and carboxyl terminals is also an important factor in determining activity at the strychnine-insensitive glycine receptor. In comparison to glycine, interterminal chain lengths greater than one carbon reduce (beta-alanine, two carbons) or eliminate (GABA, three carbons) activity. This is also true for activity of ligands at the NMDA recognition site.46,60
Substitutions of the amino and carboxyl terminals are also important determinants of activity. Replacement of the carboxyl terminal of beta-alanine with a sulfonic group (taurine) eliminates activity. In contrast, addition of a methylester moiety to the carboxyl terminal of glycine (glycine methylester) maintains pronounced activity. Methylation of the primary amine of glycine (N-methyl-glycine) eliminates activity at the glycine binding site.5'.56 Of note, methylation of aspartate (N-methyl-aspartate) increases activity at the NMDA receptor, whereas larger alkylations decrease activity.4h
Addition of heteroatoms in the carbon chain connecting the acidic groups appears to be well tolerated. Replacement of the methylene group of homocysteic acid with an oxygen atom (serine-O-sulfate) maintains activity. Of the dipeptides with glycine at the gamma-carboxy terminal the order of potency of the acidic terminal of glycine is COOH > PO,H, > SO,H. Furthe~ore, dipeptides with glycine at the N-terminal are less effective than those with glycine at the C-terminal and non-glycine containing dipeptides are not active at all.
Several common structural features of reported antagonists of the strychnine-insensitive glycine site imply that comformationally restricted and heterocyclic structures are important determinants of antagonists of the glycine receptor. These include the cyclic anhydric analog of GABA, HA-966,'4.h0 cycloleucine,5Sa kynurenate, its analog 7-chlorokynurenate,lh and two heterocyclic quinoxaline derivatives &cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 6,7-dinitroquinoxaline-2.3-dione (DNQX).'" The common structural features of these glycine receptor antagonists include planar conformationat restriction and functional groups up to at least four atoms from the alpha-amino acid carbon.
Several other putative antagonists of the NMDA recognition site also inhibit strychnine-insensitive glycine binding (gamma-D-glutamylglycine, ASP-AMP. D-alpha-aminoad~pate, kynurenatef. z4.4ft.h" In fact, gamma-D-glutamylglycine is more effective in inhibiting glycine binding than NMDA-sensitive glutamate binding (unpublished observation 
CON('I.lISION
The results presented in this paper provide the first detailed information about the regional brain distribution of strychnine-insensitive
[jH]glycine binding.
The data extend earlier descriptions of the pharmacology of strychnine-insensitive ['Hlglycine binding and demonstrate that this labeled site corresponds to the physiologically defined site. The results also indicate that the stoichiometry between the modulatory sites comprising the NMDA rcccptor complex var> among brain regions. The preliminary studies of the structure--activity relations of' strychnine-inscnsitivc glycine receptor ligands could be of considerable value in the development of selective agonists and antagonists for the glycine modulatory site. Antagonists of the strychnine-insensitive glycine site may prove to be an effective treatment in inherited juvcnilc non-ketotic hyperglycinemia"' as well as other ncurologic disorders.",'X,"'J' " " 
41.
42.
